Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK, PAR V ALUE $0.001 PER SHARE
-
Shares outstanding
-
79,310,345
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
11,182,776
-
Shares change
-
+317,501
-
Total reported value, excl. options
-
$47,050,210
-
Value change
-
+$1,816,100
-
Put/Call ratio
-
441%
-
Number of buys
-
22
-
Number of sells
-
-23
-
Price
-
$4.22
Significant Holders of CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) as of Q4 2022
76 filings reported holding CRMD - CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE as of Q4 2022.
CorMedix Inc. - COMMON STOCK, PAR V ALUE $0.001 PER SHARE (CRMD) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11,182,776 shares
of 79,310,345 outstanding shares and own 14% of the company stock.
Largest 10 shareholders include NOMURA HOLDINGS INC (2,952,334 shares), VANGUARD GROUP INC (1,797,326 shares), Elliott Investment Management L.P. (1,550,523 shares), BlackRock Inc. (640,818 shares), MILLENNIUM MANAGEMENT LLC (582,437 shares), GEODE CAPITAL MANAGEMENT, LLC (356,917 shares), Cresset Asset Management, LLC (329,796 shares), BANK OF MONTREAL /CAN/ (286,900 shares), CITADEL ADVISORS LLC (193,369 shares), and Spinnaker Capital LLC (175,384 shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.